Literature DB >> 35710610

Ranking reprogramming factors for cell differentiation.

Jennifer Hammelman1,2, Tulsi Patel3,4,5, Michael Closser3,4,5, Hynek Wichterle3,4,5, David Gifford6,7,8,9.   

Abstract

Transcription factor over-expression is a proven method for reprogramming cells to a desired cell type for regenerative medicine and therapeutic discovery. However, a general method for the identification of reprogramming factors to create an arbitrary cell type is an open problem. Here we examine the success rate of methods and data for differentiation by testing the ability of nine computational methods (CellNet, GarNet, EBseq, AME, DREME, HOMER, KMAC, diffTF and DeepAccess) to discover and rank candidate factors for eight target cell types with known reprogramming solutions. We compare methods that use gene expression, biological networks and chromatin accessibility data, and comprehensively test parameter and preprocessing of input data to optimize performance. We find the best factor identification methods can identify an average of 50-60% of reprogramming factors within the top ten candidates, and methods that use chromatin accessibility perform the best. Among the chromatin accessibility methods, complex methods DeepAccess and diffTF have higher correlation with the ranked significance of transcription factor candidates within reprogramming protocols for differentiation. We provide evidence that AME and diffTF are optimal methods for transcription factor recovery that will allow for systematic prioritization of transcription factor candidates to aid in the design of new reprogramming protocols.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35710610     DOI: 10.1038/s41592-022-01522-2

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   47.990


  77 in total

1.  An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues.

Authors:  M Ryan Corces; Alexandro E Trevino; Emily G Hamilton; Peyton G Greenside; Nicholas A Sinnott-Armstrong; Sam Vesuna; Ansuman T Satpathy; Adam J Rubin; Kathleen S Montine; Beijing Wu; Arwa Kathiria; Seung Woo Cho; Maxwell R Mumbach; Ava C Carter; Maya Kasowski; Lisa A Orloff; Viviana I Risca; Anshul Kundaje; Paul A Khavari; Thomas J Montine; William J Greenleaf; Howard Y Chang
Journal:  Nat Methods       Date:  2017-08-28       Impact factor: 28.547

2.  Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons.

Authors:  Naomi Habib; Yinqing Li; Matthias Heidenreich; Lukasz Swiech; Inbal Avraham-Davidi; John J Trombetta; Cynthia Hession; Feng Zhang; Aviv Regev
Journal:  Science       Date:  2016-07-28       Impact factor: 47.728

3.  Single-cell messenger RNA sequencing reveals rare intestinal cell types.

Authors:  Dominic Grün; Anna Lyubimova; Lennart Kester; Kay Wiebrands; Onur Basak; Nobuo Sasaki; Hans Clevers; Alexander van Oudenaarden
Journal:  Nature       Date:  2015-08-19       Impact factor: 49.962

4.  Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens.

Authors:  Atray Dixit; Oren Parnas; Biyu Li; Jenny Chen; Charles P Fulco; Livnat Jerby-Arnon; Nemanja D Marjanovic; Danielle Dionne; Tyler Burks; Raktima Raychowdhury; Britt Adamson; Thomas M Norman; Eric S Lander; Jonathan S Weissman; Nir Friedman; Aviv Regev
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

5.  A single-cell molecular map of mouse gastrulation and early organogenesis.

Authors:  Blanca Pijuan-Sala; Jonathan A Griffiths; Carolina Guibentif; Tom W Hiscock; Wajid Jawaid; Fernando J Calero-Nieto; Carla Mulas; Ximena Ibarra-Soria; Richard C V Tyser; Debbie Lee Lian Ho; Wolf Reik; Shankar Srinivas; Benjamin D Simons; Jennifer Nichols; John C Marioni; Berthold Göttgens
Journal:  Nature       Date:  2019-02-20       Impact factor: 69.504

6.  Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity.

Authors:  Christof Angermueller; Stephen J Clark; Heather J Lee; Iain C Macaulay; Mabel J Teng; Tim Xiaoming Hu; Felix Krueger; Sebastien Smallwood; Chris P Ponting; Thierry Voet; Gavin Kelsey; Oliver Stegle; Wolf Reik
Journal:  Nat Methods       Date:  2016-01-11       Impact factor: 28.547

7.  Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain.

Authors:  Blue B Lake; Song Chen; Brandon C Sos; Jean Fan; Gwendolyn E Kaeser; Yun C Yung; Thu E Duong; Derek Gao; Jerold Chun; Peter V Kharchenko; Kun Zhang
Journal:  Nat Biotechnol       Date:  2017-12-11       Impact factor: 54.908

8.  Single-cell ATAC-Seq in human pancreatic islets and deep learning upscaling of rare cells reveals cell-specific type 2 diabetes regulatory signatures.

Authors:  Vivek Rai; Daniel X Quang; Michael R Erdos; Darren A Cusanovich; Riza M Daza; Narisu Narisu; Luli S Zou; John P Didion; Yuanfang Guan; Jay Shendure; Stephen C J Parker; Francis S Collins
Journal:  Mol Metab       Date:  2019-12-20       Impact factor: 7.422

9.  RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures.

Authors:  Maurizio Pellegrino; Adam Sciambi; Jamie L Yates; Joshua D Mast; Charles Silver; Dennis J Eastburn
Journal:  BMC Genomics       Date:  2016-05-17       Impact factor: 3.969

10.  Single-cell chromatin accessibility maps reveal regulatory programs driving early mouse organogenesis.

Authors:  Blanca Pijuan-Sala; Nicola K Wilson; Jun Xia; Xiaomeng Hou; Rebecca L Hannah; Sarah Kinston; Fernando J Calero-Nieto; Olivier Poirion; Sebastian Preissl; Feng Liu; Berthold Göttgens
Journal:  Nat Cell Biol       Date:  2020-03-30       Impact factor: 28.824

View more
  1 in total

1.  Benchmarking of ATAC Sequencing Data From BGI's Low-Cost DNBSEQ-G400 Instrument for Identification of Open and Occupied Chromatin Regions.

Authors:  Marina Naval-Sanchez; Nikita Deshpande; Minh Tran; Jingyu Zhang; Majid Alhomrani; Walaa Alsanie; Quan Nguyen; Christian M Nefzger
Journal:  Front Mol Biosci       Date:  2022-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.